Skip to main content

Xenon Pharmaceuticals Inc.

XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001582313

In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.

Q2 2026 vs. Q1 2026

How the institutions holding Xenon Pharmaceuticals Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of XENE: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders2902315+27
Shares100.2M4.18M101.1M+5.07M (+5.3%)
Value$5.80B$242.9M$6.10B+$538.5M (+9.7%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to XENE in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC4,186,519$252.7M0.10%
Marshall Wace, LLP689,342$41.6M0.04%
Panagora Asset Management Inc664,031$40.1M0.12%
Jones Hill Capital LP367,900$22.2M4.72%
Man Group plc310,617$18.7M0.03%
Point72 Asset Management, L.P.130,378$7.87M0.01%
Squarepoint Ops LLC112,869$6.81M0.01%
Capital Fund Management S.A.84,470$5.10M0.04%
Walleye Capital LLC76,955$4.65M0.02%
Royce & Associates LP65,032$3.93M0.03%
Diversified Trust Co39,222$2.37M0.04%
Oak Ridge Investments LLC38,559$2.33M0.13%
Dimensional Fund Advisors LP36,595$2.21M0.00%
Seven Fleet Capital Management LP33,300$2.08M0.34%
Dark Forest Capital Management LP22,234$1.34M0.09%
Capricorn Fund Managers Ltd20,900$1.26M0.10%
Magnetar Financial LLC18,213$1.10M0.01%
IMC-Chicago, LLC15,083$910.4K0.01%
Fieldview Capital Management, LLC13,930$840.8K0.24%
Capstone Investment Advisors, LLC8,925$538.7K0.00%
Allstate Corp8,180$493.7K0.00%
Himension Fund7,666$462.7K0.03%
Blackstone Group Inc.7,608$459.2K0.00%
Blair William & Co6,730$406.2K0.00%
Gsa Capital Partners LLP6,293$380.0K0.02%
Captrust Financial Advisors5,572$336.3K0.00%
Mercer Global Advisors Inc4,193$253.1K0.00%
Abel Hall, LLC3,809$229.9K0.04%
Inscription Capital, LLC3,431$207.1K0.02%
Susquehanna Fundamental Investments, LLC3,405$205.5K0.00%
Natixis2,037$123.0K0.00%
Harbor Investment Advisory, LLC1,393$84.1K0.01%
Nykredit A/S1,102$66.5K0.00%
Global Retirement Partners, LLC873$52.7K0.00%
Optiver Holding B.V.449$27.1K0.00%
SRS Capital Advisors, Inc.441$26.6K0.00%
Versant Capital Management, Inc221$13.3K0.00%
IFG Advisory, LLC215$13.0K0.00%
Flagship Wealth Advisors, LLC100$6.04K0.00%
Clearstead Advisors, LLC94$5.67K0.00%
Continuum Advisory, LLC48$2.90K0.00%
Silver Grove Financial Group, Inc.39$2.35K0.00%
Cape Investment Advisory, Inc.38$2.29K0.00%
SJS Investment Consulting Inc.37$2.23K0.00%
Ameritas Advisory Services, LLC35$2.11K0.00%
Bessemer Group Inc14$1.00K0.00%
Ares Financial Consulting, LLC12$7240.00%
SHP Wealth Management11$6640.00%
Cornerstone Financial Management LLC10$6040.00%

Sold out (22)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (2)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XENE in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC4,175,982$242.9M
CWM, LLC510$29.7K